This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2023 Information Coming Soon!

Tracey Mullen
Senior Vice President of Operations at Abveris Antibody, a Division of Twist Bioscience

Profile

 Tracey Mullen is a chemical-biological engineer from MIT who began her career as an Antibody Discovery Scientist at a startup contract research organization specializing in in vivo antibody discovery. In 2013, she joined the Antibody Discovery team at Biogen where she helped implement the technology transfer of the Adimab yeast display platform. In June of 2018, Tracey joined Abveris as the Chief Operating Officer, and is now the SVP of Operations managing for in vivo discovery campaigns.

Agenda Sessions

  • MORNING SCIENTIFIC BRIEFING: Rapid, Function-Foward mAb Discovery Against a Cell Surface Target via Concurrent Use of Humanized and Hyperimmune Mice

    07:30